Quantora — Markets, Analysis & Valuation

Valuations are estimates only, produced by transparent models for education and research. This is not financial advice. Verify before trading.

AbbVie Inc — Valuation Dashboard

Download PDF report Company page

MARKET PRICE

221.23

DCF (FCFF)

49.30

-77.72% vs market

COMPARABLES

n/a

DIVIDEND (DDM)

n/a

ASSET-BASED

n/a

QUALITY SCORE

…

Implied values per model vs market — models disagree by design; each makes different assumptions. Estimates only.

Composite signal

Watch

Health Care · sig-v0.1 · confidence 75/100

Value

Quality

Momentum

Low-vol

Composite 38 (21th percentile in Health Care)

MOS

Value

Band

Trend

The model flags: MOS -351.3% vs 40% needed [fail] · relative value [fail] · composite 21 pct, band out [fail] · trend confirmed [pass]. Confidence 75/100.

Educational model classification — not a buy/sell recommendation, and not personalised. Verify before trading.

As of 2026-06-17 06:00 UTC.

Assumptions

Year-1 revenue growth %

Terminal growth %

Target operating margin %

Tax rate %

WACC override % (blank = CAPM)

Defaults derive from the company's statements; risk-free rate source: FRED:DGS10 (4.43 %). Any change is recorded as a user override in the audit trail.

Inputs from statements

Revenue (latest FY)	61.16B
Operating margin	24.6 %
Net debt	59.27B
Diluted shares	1.77B
Beta	1.00 (default)
Market price	221.23

Fundamentals as of 2025-12-31 · Source: DEMO

INTRINSIC VALUE / SHARE

49.30

MARKET PRICE

221.23

UPSIDE

-77.72%

MARGIN OF SAFETY

-348.8 %

Enterprise value 146.68B · Equity value 87.41B · WACC 8.31 % · Formula v1.0 · Audit run 72fb2e8f

No beta available — defaulting to 1.0.

Bull/base/bear scenarios, sensitivity tables and the comparable / dividend / asset-based models require the Pro tier — the DCF summary above is included in Free. (Billing integration pending; tiers live in the subscriptions table.)